secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001104659-23-105381
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconova receives Nasdaq bid price deficiency notice; 180-day cure period to March 2024
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sep 25, 2023 for failure to maintain $1.00 minimum bid price.
- Has until March 25, 2024 to regain compliance with closing bid >=$1 for 10 consecutive days.
- If not cured, may qualify for second 180-day period by meeting other standards and notifying intent to reverse split.
- Company says it will monitor options but cannot assure compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465923105381/0001104659-23-105381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465923105381/tm2327211d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-105381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer